https://www.selleckchem.com/pr....oducts/zasocitinib.h
Madelung disease is a rare lipid metabolic disorder, and most cases are sporadically reported. There are currently no systematic reviews summarizing the epidemiological and clinical characteristics of this disease. The purpose of the current article is to extract and analyze the existing evidence concerning Madelung disease derived from case series in order to provide adequate treatments for patients based on a more comprehensive understanding of the disease. PubMed, Embase, and Web of Science databases were queried for relevant art
Like
Comment
Share
